Pluvicto radiopharmaceutical
Ended Awarded Last action
- Contract number
- 36C25226F0037
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $365,521
Award facts
- Contract value 100% obligated
- $365,520.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60612, USA
Award details come from SAM.gov/FPDS.
About this award
On November 7, 2025, the Department of Veterans Affairs' Veterans Integrated Service Network 12 (VISN 12) awarded a delivery order valued at $365,520.54 to Novartis Pharmaceuticals Corporation for PLUVICTO radiopharmaceutical. This firm fixed-price contract represents a delivery order issued against Novartis' existing Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and will be performed in Chicago, Illinois, with an ultimate completion date of January 31, 2026. The award utilizes no small business set-aside designation, reflecting Novartis' status as a large pharmaceutical manufacturer competing directly in the federal marketplace. PLUVICTO is an advanced radiopharmaceutical used in cancer treatment, aligning with the VA's commitment to providing innovative medical therapies to veterans.
This delivery order is issued under one of Novartis' significant Indefinite Delivery Vehicles with the VA—specifically the company's Blanket Purchase Agreement valued at $7,480,000 through September 30, 2030, which supports PLUVICTO procurement across VISN 10. Novartis maintains a substantial federal presence in pharmaceutical contracting, with additional IDC awards from the Defense Health Agency and multiple contract awards across various Veterans Integrated Service Networks focused on cancer therapies and nuclear medicine products, demonstrating the company's established role as a key supplier of specialized medical treatments to federal healthcare systems.
Quick answers
Who was awarded contract 36C25226F0037?
36C25226F0037 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on November 7, 2025.
How much is contract 36C25226F0037 worth?
The government has obligated $365,521 on 36C25226F0037.
Is contract 36C25226F0037 an order under another contract?
Yes. 36C25226F0037 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25226F0037 competed?
The extent of competition for 36C25226F0037 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award